Skip to content

An open-labeled preliminary study of the effect of Peucedanum japonicum Thunb (PJT) ingestion on serum adiponectin secretion for healthy volunteer subjects

An open-labeled preliminary study of the effect of Peucedanum japonicum Thunb (PJT) ingestion on serum adiponectin secretion for healthy volunteer subjects - An open-labeled preliminary study of the effect of PJT ingestion on serum adiponectin secretion for healthy volunteer subjects

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000013683
Enrollment
45
Registered
2014-04-12
Start date
2012-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy volunteer subjects

Interventions

1,260 mg/day of a PJT tablet products for 3 months (Tyojusyokuzai-kenkyusyo, Tokyo, Japan)

Sponsors

Osaka University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. to be simple obese subjects with over 20kg/m2 of BMI 2. to be the subjects over 20 years old on informed consent before entering the study 3. to be the subjects who gave their written informed consent before entering the study

Exclusion criteria

Exclusion criteria: 1. to be the subjects with severe abnormalites of liver or kidney functions 2. to be the subjects allergic to PJT ingredients 3. to be the subjects in pregnancy or breast feeding 4. to be the subjects inadequate to participate in this trial, judged by the responsible physicians

Design outcomes

Primary

MeasureTime frame
the amount of serum adiponectin secretion

Secondary

MeasureTime frame
body weight and abdominal circumference

Countries

Japan

Contacts

Public ContactSawako Sawa

Isen-tyo community health center Isen-tyo community health center

isen-ph@po5.synapse.ne.jp0997-86-2124

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026